Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

MSLN overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

MSLN overexpression + TP53 mutation (1)

MSLN overexpression + TP53 mutation (1)

›

MSLN overexpression	Ovarian Cancer	MSLN overexpression	Ovarian Cancer	TC-210 Sensitive: C3 – Early Trials TC-210 Sensitive : C3	TC-210 Sensitive: C3 – Early Trials TC-210 Sensitive : C3
MSLN overexpression	Malignant Pleural Mesothelioma	MSLN overexpression	Malignant Pleural Mesothelioma	TC-210 Sensitive: C3 – Early Trials TC-210 Sensitive : C3	TC-210 Sensitive: C3 – Early Trials TC-210 Sensitive : C3
MSLN overexpression	Non Small Cell Lung Cancer	MSLN overexpression	Non Small Cell Lung Cancer	afatinib Resistant: D – Preclinical afatinib Resistant : D	afatinib Resistant: D – Preclinical afatinib Resistant : D
MSLN overexpression	Acute Myelogenous Leukemia	MSLN overexpression	Acute Myelogenous Leukemia	BAY 94-9343 Sensitive: D – Preclinical BAY 94-9343 Sensitive : D	BAY 94-9343 Sensitive: D – Preclinical BAY 94-9343 Sensitive : D
MSLN overexpression	Solid Tumor	MSLN overexpression	Solid Tumor	HK013 Sensitive: D – Preclinical HK013 Sensitive : D	HK013 Sensitive: D – Preclinical HK013 Sensitive : D